Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine to Reduce AKI After Cardiac Surgery (Glacé)
NCT04019184Phase 3Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Jul 2019
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
A Phase 3 trial of alanyl glutamine in acute kidney injury (AKI), sponsored by Universitätsklinikum Münster. Started Jul 2019; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04019184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04019184.